Clinical trial
Limited Adjuvant Endocrine Therapy for Low Risk Breast Cancer
NCT03917082
Study timeline
Study start (actual)2019-09-23Date precision: day
Registry last updated2023-06-15
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Breast Cancer Femaleunresolved
Hormone Receptor Positive Tumorunresolved
Interventions
Tamoxifen CitrateDRUG · verified · RxNorm: tamoxifen citrate
Sponsors & collaborators
British Columbia Cancer Agencylead sponsor
Canadian Cancer Society (CCS)collaborator
NanoString Technologies, Inc.collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03917082 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.